DIGITAL FLUOROSCOPY SYSTEM MARKET ANALYSIS

Digital Fluoroscopy System MarketSize and Trends

Digital Fluoroscopy System Market Dynamics:-

Increasing number of orthopedic surgeries and angiography are major drivers for growth of global digital fluoroscopy system market. According to a survey conducted by American Academy of orthopedic surgeons, in 2014, more than six million patients were reported for knee replacement surgeries, more than three million patients were reported for hip replacement surgeries and more than four million patients were reported for spinal fusion surgeries.

Moreover, innovation in fluoroscopy devices is expected to fuel digital fluoroscopy system market growth. For instance, in 2015, Care Stream Health Corporation launched Carestream DRX Excel and Carestream DRX Excel Plus, this devices enhance workflow using fluoroscopy. These devices records both fluoroscopy and radiography sequences. Approvals of new products by regulatory bodies are also driving growth of the digital fluoroscopy system market size. For instance, in April 2018, Afga Healthcare received Food and Drug Administration (FDA) approval for DR multipurpose imaging system. It is a solution for digital radiography, digital fluoroscopy, and advanced clinical applications such as use of image processing software ‘DYNAMIC MUSICA’ for both static and dynamic (moving) images.

Furthermore, mergers and acquisitions by key players are boosting growth of the digital fluoroscopy system market. For instance, in 2016, Canon Inc. acquired Toshiba’s Medical Equipment Unit. Canon is focused on developing new medical imaging, digital radiography, and fluoroscopy solutions along with Health IT software solutions.

Collaborative agreement by key players for service expansion is expected to drive digital fluoroscopy system market growth. For instance, in 2015, GE Healthcare entered into a 7-year collaborative agreement with Temple University Health System to expand radiology-based services. This initiative was also undertaken to address challenges pertaining to market competition, cost control and patient outcomes.